Sign In
Buy DTC
$0.0940
+0 (+0%)
At Close: Jul 21, 2025
Defence Therapeutics Expands Collaboration with Canadian Nuclear Laboratories to Accelerate Its Proprietary Radiopharmaceutical Pipeline
08:40am, Wednesday, 28'th Jan 2026
Montreal, Quebec--(Newsfile Corp. - January 28, 2026) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a publicly traded biotechnology and precision intra
Defence Therapeutics Sharpens Strategic Focus on Precision Drug Delivery to Unlock the Full Potential of Cancer Biologics
03:15am, Wednesday, 21'st Jan 2026
Montreal, Quebec--(Newsfile Corp. - January 21, 2026) - Defence Therapeutics Inc., (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a publicly traded biotechnology company, today ann
Nike's Strong Q2 Results Overshadowed by Cautious Holiday Outlook
05:14pm, Friday, 19'th Dec 2025
Nike (NKE) exceeded expectations in its Q2 results, delivering both top and bottom-line growth. Despite this, a cautious outlook for the holiday quarter and ong
Nike to report Q2 earnings amid weak DTC trends, mixed sentiment
03:58pm, Wednesday, 10'th Dec 2025
Nike Inc (NYSE:NKE, XETRA:NKE) will report its fiscal second quarter results on December 18, with UBS analysts expecting a relatively muted reaction from Wall Street despite signs of uneven momentum
Metalsource Mining Announces Eligibility for Depository Trust Company (DTC) Services
08:00am, Thursday, 04'th Dec 2025
Vancouver, British Columbia--(Newsfile Corp. - December 4, 2025) - Metalsource Mining, Inc. (CSE: MSM) (FSE: E9Z) (OTCQB: SFRIF) ("Metalsource" or the "Company"), is pleased to announce that its commo
Montreal, Quebec--(Newsfile Corp. - December 4, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a biotechnology company advancing a proprietary i
Defence Therapeutics Announces Convertible Debenture Conversion
06:02pm, Friday, 21'st Nov 2025
Montreal, Quebec--(Newsfile Corp. - November 21, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a leading biotechnology company pioneering next-g
Amer Sports Surges on Strong Q3 Results and Raised FY25 Guidance
02:14pm, Tuesday, 18'th Nov 2025
Amer Sports (AS) shares are climbing after the company reported impressive Q3 results. The Finland-based athletic company exceeded expectations with a 30% year-
Media Giants Eye Warner Bros. Discovery as Industry Consolidation Intensifies
11:14am, Friday, 14'th Nov 2025
Paramount Skydance (PSKY), Comcast (CMCSA), and Netflix (NFLX) are gearing up to bid for Warner Bros. Discovery (WBD) ahead of the November 20 deadline. This mo
Disney's Mixed Q4 Results: EPS Beat, Revenue Miss, and Strategic Shifts
12:14pm, Thursday, 13'th Nov 2025
Walt Disney (DIS) slightly exceeded Q4 EPS expectations but fell short on revenue, which declined by 0.5% year-over-year to $22.46 billion. This marks Disney's
Pavilion to Demonstrate AI and Digital Twins Use Cases Aligned to Topical Panels and Sessions on National Defense Strategy and Naval Shipbuilding Advancements Arlington, Virginia--(Newsfile Corp. - No
On Holding Surges 19% on Strong Q3 Earnings and Raised Guidance
11:14am, Wednesday, 12'th Nov 2025
On Holding (ONON) saw a significant 19% increase in its stock after a strong Q3 earnings report and an upward revision of its guidance. The Swiss athletic footw
Paramount Skydance (PSKY) Gains Momentum Despite Mixed Q3 Results
12:14pm, Tuesday, 11'th Nov 2025
Paramount Skydance (PSKY) reported its first earnings since the $8.4 billion Skydance merger, closed on August 7, 2025. Despite a mixed Q3 performance, shares r
Solo Brands, Inc. Announces Third Quarter 2025 Results
07:30am, Thursday, 06'th Nov 2025
Solo Brands Accelerates Structural Cost Reduction to Match Current Demand Levels; Delivers $11 Million of Operating Cash in Q3, Marking Second Consecutive Quarter of Positive Cash Flow Solo Brands Acc
Defence Therapeutics Demonstrates Strong Preclinical in Vivo Efficacy Results Evaluating Accum-Kadcyla in Breast Cancer Models
03:15am, Tuesday, 04'th Nov 2025
Montreal, Quebec--(Newsfile Corp. - November 4, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a leading biotechnology company specialized in drug
